ALK and non-small cell lung carcinoma: Only FISH using a break-apart probe kit (Vysis LSI ALK Dual Color, break-apart rearrangement probe; Abbott Molecular, Abbott Park, IL) is approved by the FDA for the treatment of proven ALK-positive NSCLC.